Tamiflu correspondence with the World Health Organization

WHO logo

The WHO correspondence begins with an email from Cochrane Collaboration researcher Tom Jefferson in February 2012. He asks WHO scientists how its review process had led to it including oseltamivir in its March 2011 Essential Medicines List.

Had it asked the manufacturers of neuramindase inhibitors for the unpublished trial data? Also, what had WHO scientists made of Cochrane’s conclusion "that there is no evidence that oseltamivir can limit the spread of influenza." The WHO told Jefferson that it was currently developing a standard guideline on clinical management of influenza virus infection. Secondly, it had commissioned several evidence reviews, including one on oseltamivir that was set to appear soon in a peer reviewed medical journal.

 

 

All rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.

Automated reply from WHO

Competing interests: No competing interests

28 March 2013
Sylvie Briand
Director
Pandemic and Epidemic Disease Department
WHO
Click to like:
18

Chris Del Mar requests that WHO answer his concerns regarding Tamiflu's inclusion on the Essential Medicines List

Competing interests: No competing interests

28 March 2013
Chris Del Mar
Professor of primary care research and Coordinating Editor of the Cochrane Acute Respiratory Infections Group
Bond University
Queensland, Australia
Click to like:
25

Dr Sylbie Briand responds to Chris Del Mar

Competing interests: No competing interests

22 March 2013
Sylvie Briand
Director
Pandemic and Epidemic Disease Department
WHO
Click to like:
25

Corresepondance to Dr Sylvie Briand, regarding the latest update of the WHO Essential Medicines List.

Competing interests: No competing interests

19 March 2013
Chris Del Mar
Coordinating editor
Neuraminidase inhibitors for influenza, Cochrane review team
Cochrane Acute Respiratory Infections Group
Bond University, Queensland, Australia
Click to like:
18
23 October 2012
Tom Jefferson
Researcher
Peter Doshi
Cochrane Collaboration
Rome
Click to like:
63